2015 annual financial data
BioCryst Pharmaceuticals 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was -27.18%.
Operating income was -39,444,000 USD and net income was -43,019,000 USD.
Operating cash flow was -13,116,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 48,257,000 USD
- Operating income
- -39,444,000 USD
- Net income
- -43,019,000 USD
- Operating cash flow
- -13,116,000 USD